sphingolipids
Summary
Sphingolipids are membrane lipids built on a sphingosine backbone, prominent in neural tissue (myelin) and cell signaling. Their catabolism requires specific lysosomal enzymes, and deficiencies in these enzymes cause a group of inherited disorders called sphingolipidoses (lysosomal storage diseases).
Detail
Sphingolipids consist of a sphingosine backbone linked to a fatty acid (forming ceramide) and a polar head group, which can be a phosphate/alcohol (sphingomyelin), a simple sugar (cerebrosides), or complex oligosaccharides (gangliosides). They are essential components of cell membranes, particularly abundant in the myelin sheath of neurons, and play roles in cell signaling, apoptosis, and cell recognition. Ceramide itself is a key second messenger involved in stress responses, apoptosis, and cell cycle arrest.
Clinically, sphingolipids are most high-yield in the context of lysosomal storage diseases (sphingolipidoses), which result from deficiencies in specific lysosomal hydrolases needed to degrade sphingolipids, leading to their pathological accumulation. Key examples include: - Tay-Sachs disease: hexosaminidase A deficiency → GM2 ganglioside accumulation; cherry-red macula, no hepatosplenomegaly, progressive neurodegeneration, developmental regression - Niemann-Pick disease: sphingomyelinase deficiency → sphingomyelin accumulation; hepatosplenomegaly, cherry-red macula, foam cells - Gaucher disease: glucocerebrosidase deficiency → glucocerebroside accumulation; most common lysosomal storage disease, hepatosplenomegaly, bone crises, Gaucher cells (crumpled tissue paper macrophages) - Fabry disease: alpha-galactosidase A deficiency → globotriaosylceramide (Gb3) accumulation; X-linked, angiokeratomas, peripheral neuropathy, renal and cardiovascular disease - Metachromatic leukodystrophy: arylsulfatase A deficiency → sulfatide accumulation; demyelination - Krabbe disease: galactocerebrosidase deficiency → psychosine accumulation; globoid cells, severe neurodegeneration
Most sphingolipidoses are autosomal recessive except Fabry disease, which is X-linked recessive. Diagnosis often involves enzyme activity assays and genetic testing. Treatment options for some (e.g., Gaucher, Fabry) include enzyme replacement therapy. Understanding the specific enzyme deficiency, accumulated substrate, and characteristic clinical findings for each sphingolipidosis is essential for USMLE Step 1.
Sources
- First Aid for the USMLE Step 1
- Lippincott Illustrated Reviews: Biochemistry
- Robbins Basic Pathology
Reviewed by AnkiBoss editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.